吸烟和戒烟对多细胞血症患者血液学参数的影响
Kadir Ilkkilic1, Dilek Karadogan2, Tahsin Gökhan Telatar3
1Department of Hematology, School of Medicine, Recep Tayyip Erdogan University, Rize, Turkey.
Open medicine (Warsaw, Poland)
|May 5, 2025
概括
戒烟干预措施有效降低了多细胞血症患者的血液学参数. 戒烟改善了关键的血液标志物,证明了这些干预措施对多细胞血症管理的价值.
科学领域:
- 血液学 血液学 血液学
- 公共卫生 公共卫生
- 临床医学 临床医学
背景情况:
- 对多细胞血症患者的戒烟干预措施的研究有限.
- 吸烟在多细胞血症患者中很普遍,影响了血液学参数.
- 了解戒烟的影响对于管理多细胞血症至关重要.
研究的目的:
- 研究戒烟对多细胞血症患者血液学参数的影响.
- 评估戒烟干预措施在这个患者群体中的有效性.
主要方法:
- 在血液外科诊所进行前性研究 (2022年11月 - 2023年5月).
- 根据吸烟状况分类的患者;为目前的吸烟者提供干预措施.
- 血液参数在基线和3个月后随访的比较.
主要成果:
- 在142名多细胞血症患者中,65.4%的患者在基线时是目前的吸烟者.
- 51%的活跃吸烟者在干预3个月后成功戒烟.
- 活跃吸烟者血红蛋白 (Hb) 和血红素 (Hct) 较高;这些在戒烟后下降.
结论:
- 戒烟干预措施对多细胞血症患者有效.
- 戒烟导致关键血液学标志物显著改善.
- 干预对于管理多细胞血症和改善患者的治疗结果至关重要.
相关概念视频
Disorders of Erythrocytes
722
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
722
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Factors Affecting Erythropoiesis
2.9K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
2.9K
Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.6K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.6K


